|Bid||1,580.00 x 175400|
|Ask||1,610.00 x 417900|
|Day's range||1,579.00 - 1,606.50|
|52-week range||1,446.50 - 1,745.56|
|PE ratio (TTM)||46.51|
|Dividend & yield||1.00 (4.66%)|
|1y target est||N/A|
Analysts expect to see a growth of ~11.4% in GlaxoSmithKline’s (GSK) 2Q17 revenues, which are expected to total nearly 7.3 billion British pounds.
For 2Q17, analysts estimate that GSK's revenues will rise ~11.4% to ~7.3 billion pounds, as compared to ~6.5 billion pounds for 2Q16.
We have three pharma giants that are set to report second-quarter results on Jul 26. Let's see how things are shaping up for this quarter.